We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

150 hedge funds and large institutions have $2.87B invested in Legend Biotech in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more call options, than puts

Call options by funds: $47.7M | Put options by funds: $15.5M

55% more capital invested

Capital invested by funds: $1.85B → $2.87B (+$1.02B)

45% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 22

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

6% more funds holding

Funds holding: 141 → 150 (+9)

0.39% more ownership

Funds ownership: 16.7% → 17.09% (+0.39%)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

Holders
150
Holders Change
+9
Holders Change %
+6.38%
% of All Funds
2.53%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
32
Increased
50
Reduced
50
Closed
22
Calls
$47.7M
Puts
$15.5M
Net Calls
+$32.2M
Net Calls Change
+$25.8M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$179M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$32M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24M
4
ITP
Iron Triangle Partners
Connecticut
+$20.9M
5
SC
Samlyn Capital
New York
+$19.2M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$106M
2
BBA
Baker Bros. Advisors
New York
-$48.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$25.9M
4
PA
Perceptive Advisors
New York
-$22.4M
5
CII
Capital International Inc
California
-$22.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
$26.7M +$13.5M +320,007 +194%
JP Morgan Chase
27
JP Morgan Chase
New York
$26.2M +$3M +70,979 +18%
FFM
28
FengHe Fund Management
Singapore
$26.1M -$22.1M -522,451 -52%
SC
29
Samlyn Capital
New York
$25M +$19.2M +454,007 New
Franklin Resources
30
Franklin Resources
California
$24.7M +$17.5K +415 +0.1%
Goldman Sachs
31
Goldman Sachs
New York
$23M +$2.17M +51,464 +14%
RSCM
32
Rock Springs Capital Management
Maryland
$19.6M -$2.35M -55,617 -14%
DCM
33
Driehaus Capital Management
Illinois
$17.4M +$13.4M +317,117 New
Barclays
34
Barclays
United Kingdom
$16.1M +$2.01M +47,586 +19%
Bank of America
35
Bank of America
North Carolina
$15M +$549K +12,995 +5%
Allianz Asset Management
36
Allianz Asset Management
Germany
$13.9M -$2.56M -60,552 -19%
VC
37
Vivo Capital
California
$13.4M – – –
Millennium Management
38
Millennium Management
New York
$13.4M -$13.6M -322,322 -57%
Geode Capital Management
39
Geode Capital Management
Massachusetts
$13.1M +$413K +9,775 +4%
Point72 Asset Management
40
Point72 Asset Management
Connecticut
$11.7M +$8.99M +212,900 New
Deutsche Bank
41
Deutsche Bank
Germany
$11.7M -$1.36M -32,243 -13%
Legal & General Group
42
Legal & General Group
United Kingdom
$11.4M +$1.15M +27,312 +15%
ACH
43
ArrowMark Colorado Holdings
Colorado
$11.3M +$1.67M +39,589 +24%
CIS
44
Capital International Sarl
California
$8.55M -$2.97M -70,380 -31%
Morgan Stanley
45
Morgan Stanley
New York
$8.41M +$736K +17,427 +13%
CCP
46
Clough Capital Partners
Massachusetts
$8.19M +$808K +19,134 +15%
SG Americas Securities
47
SG Americas Securities
New York
$7.74M -$570K -13,499 -9%
Mackenzie Financial
48
Mackenzie Financial
Ontario, Canada
$7.07M +$5.43M +128,488 New
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$6.81M -$10.2M -241,032 -66%
Swiss National Bank
50
Swiss National Bank
Switzerland
$6.7M – – –
1
2
3 4 5

LEGN Hedge Fund Activity: Q2 2022 in Review

150 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q2 2022, worth a combined $2.87B — up 55% from $1.85B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new LEGN positions and 22 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was HHLR Advisors, cutting an estimated $106M.

  • 150 institutional investors held Legend Biotech (LEGN) as of Q2 2022, up from 141 in Q1 2022.
  • Funds reported $2.87B of Legend Biotech stock for Q2 2022, up 55% quarter-over-quarter.
  • 32 funds opened new Legend Biotech positions in Q2 2022 and 22 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q2 2022 was Fidelity Investments, an estimated $179M added.
  • The largest Legend Biotech seller in Q2 2022 was HHLR Advisors, an estimated $106M sold.

Based on aggregated 13F filings for Q2 2022.